Insider · CIK 0001940017
Greg Redinbo
officer
Files at ACLS (AXCELIS TECHNOLOGIES INC). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | ACLS AXCELIS TECHNOLOGIES INC | FTax withholding Common Stock | -208 | $105.04 | $22k | 34,816 | 26 d ago |
| Jun 16, 2025 | ACLS AXCELIS TECHNOLOGIES INC | FTax withholding Common Stock | -734 | $68.96 | $51k | 32,869 | Jun 17, 2025 |
| May 16, 2025 | ACLS AXCELIS TECHNOLOGIES INC | FTax withholding Common Stock | -190 | $61.58 | $12k | 33,603 | May 20, 2025 |
| May 15, 2025 | ACLS AXCELIS TECHNOLOGIES INC | AGrant or award Common Stock | +6,148 | $0.00 | $0 | 28,031 | May 19, 2025 |
| May 15, 2025 | ACLS AXCELIS TECHNOLOGIES INC | AGrant or award Common Stock | +6,148 | $0.00 | $0 | 34,179 | May 19, 2025 |
| May 15, 2025 | ACLS AXCELIS TECHNOLOGIES INC | FTax withholding Common Stock | -209 | $62.67 | $13k | 33,970 | May 19, 2025 |
| May 15, 2025 | ACLS AXCELIS TECHNOLOGIES INC | FTax withholding Common Stock | -177 | $62.67 | $11k | 33,793 | May 19, 2025 |
| Feb 28, 2025 | ACLS AXCELIS TECHNOLOGIES INC | FTax withholding Common Stock10b5-1 | -471 | $54.79 | $26k | 22,632 | Mar 4, 2025 |
| Feb 28, 2025 | ACLS AXCELIS TECHNOLOGIES INC | FTax withholding Common Stock10b5-1 | -749 | $54.79 | $41k | 21,883 | Mar 4, 2025 |
| Sep 16, 2024 | ACLS AXCELIS TECHNOLOGIES INC | FTax withholding Common Stock | -236 | $98.86 | $23k | 21,678 | Nov 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.